Literature DB >> 11487722

Cardenolides and cancer.

B Stenkvist.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11487722     DOI： 10.1097/00001813-200108000-00012

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN： 0959-4973            Impact factor:   2.248


× No keyword cloud information.
  13 in total

1.  Cardenolide-induced lysosomal membrane permeabilization demonstrates therapeutic benefits in experimental human non-small cell lung cancers.

Authors:  Tatjana Mijatovic; Véronique Mathieu; Jean-François Gaussin; Nancy De Nève; Fabrice Ribaucour; Eric Van Quaquebeke; Patrick Dumont; Francis Darro; Robert Kiss
Journal:  Neoplasia       Date:  2006-05       Impact factor: 5.715

Review 2.  The sodium pump alpha1 subunit as a potential target to combat apoptosis-resistant glioblastomas.

Authors:  Florence Lefranc; Robert Kiss
Journal:  Neoplasia       Date:  2008-03       Impact factor: 5.715

3.  Cardenolide-rich fraction of Pergularia tomentosa as a novel Antiangiogenic agent mainly targeting endothelial cell migration.

Authors:  Mahya Hosseini; Mahdi Ayyari; Anna Meyfour; Sonia Piacente; Antonietta Cerulli; Alexander Crawford; Sara Pahlavan
Journal:  Daru       Date:  2020-07-01       Impact factor: 3.117

4.  A Direct Comparison of the Anticancer Activities of Digitoxin MeON-Neoglycosides and O-Glycosides: Oligosaccharide Chain Length-Dependent Induction of Caspase-9-Mediated Apoptosis.

Authors:  Anand Krishnan V Iyer; Maoquan Zhou; Neelam Azad; Hosam Elbaz; Leo Wang; Derek K Rogalsky; Yon Rojanasakul; George A O'Doherty; Joseph M Langenhan
Journal:  ACS Med Chem Lett       Date:  2010-07-12       Impact factor: 4.345

5.  Enhancing the anticancer properties of cardiac glycosides by neoglycorandomization.

Authors:  Joseph M Langenhan; Noël R Peters; Ilia A Guzei; F Michael Hoffmann; Jon S Thorson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-16       Impact factor: 11.205

6.  Role of homologous ASP334 and GLU319 in human non-gastric H,K- and Na,K-ATPases in cardiac glycoside binding.

Authors:  Rossen Radkov; Solange Kharoubi-Hess; Danièle Schaer; Nikolai N Modyanov; Käthi Geering; Jean-Daniel Horisberger
Journal:  Biochem Biophys Res Commun       Date:  2007-03-01       Impact factor: 3.575

7.  Ex vivo activity of cardiac glycosides in acute leukaemia.

Authors:  Helene Hallböök; Jenny Felth; Anna Eriksson; Mårten Fryknäs; Lars Bohlin; Rolf Larsson; Joachim Gullbo
Journal:  PLoS One       Date:  2011-01-05       Impact factor: 3.240

8.  Proscillaridin A is cytotoxic for glioblastoma cell lines and controls tumor xenograft growth in vivo.

Authors:  Emilie Denicolaï; Nathalie Baeza-Kallee; Aurélie Tchoghandjian; Manon Carré; Carole Colin; Carine Jiguet Jiglaire; Sandy Mercurio; Christophe Beclin; Dominique Figarella-Branger
Journal:  Oncotarget       Date:  2014-11-15

9.  Inhibition of Na+/K+-ATPase induces hybrid cell death and enhanced sensitivity to chemotherapy in human glioblastoma cells.

Authors:  Dongdong Chen; Mingke Song; Osama Mohamad; Shan Ping Yu
Journal:  BMC Cancer       Date:  2014-09-26       Impact factor: 4.430

10.  Anvirzel™ in combination with cisplatin in breast, colon, lung, prostate, melanoma and pancreatic cancer cell lines.

Authors:  Panagiotis Apostolou; Maria Toloudi; Marina Chatziioannou; Eleni Ioannou; Dennis R Knocke; Joe Nester; Dimitrios Komiotis; Ioannis Papasotiriou
Journal:  BMC Pharmacol Toxicol       Date:  2013-03-25       Impact factor: 2.483
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.